Clindamycin Phosphate Solution
Product Images NDC 45802-263

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 45802-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rx Serialization

A printed text panel with placeholders for product identification details, including serial number (S/N), lot number (Lot), and expiration date (Exp), intended for labeling Clindamycin Phosphate topical solution packaging.*

FDA Label Image

Structural Formula Image (Image 01)

Chemical structure of clindamycin phosphate, showing its molecular arrangement with distinct ring systems, phosphate group, and functional groups including methyl, hydroxyl, and sulfur moieties.*

FDA Label Image

Image 02

Label for Clindamycin Phosphate Topical Solution USP 1% (equivalent to 10 mg/mL clindamycin) in a package of 60 pledgets. The label includes usage instructions, storage information, and a barcode. The product is labeled for topical use only and distributed by Perrigo under Padagis Israel Pharmaceuticals Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.